La historia natural de la sensibilización fúngica en el asma
The natural history of fungal sensitization in asthma
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Resp. 2011;11:403–13.
Agarwal R, Chakrabarti A, Shah A, Gupta D, et al. Allergic broncopulmonary aspergilosis: review of the literature and proposal of new diagnostic and classification criteria. Clin Exp Allerg. 2013;43:850–73.
Agarwal R, Aggarwal N, Gupta D, Jindal K. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13:936–44.
Patterson K, Strek Mary E. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146 (5):1358-68.
Hogan C, Denning D. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Sem Resp Crit Care Med. 2011;32(6):682- 92.
Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135:805-26.
Greenberg P. When to suspect and work up allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Inmunol. 2013;111:1–4.
Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4:141-50.
Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66:679–85.
Agarwal R, Hhan A, Gupta D, Aggarwal A, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;12:e15346.
Franquet T, Müller NL, Gimenez A, Gumbe P, de la Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histolo-gic, clinical, and radiologic findings. RadioGraphics. 2001; 21:825–37.
Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax. 1994;49:586-89.
Patterson R, Greenberg PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roetgenographic. Arch Intern Med. 1986;146(5):916-18.
Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110: 685-92.
Mahdavinia M, Grammer LC. Management of allergic bronchopulmonary aspergillosis: a review and update. Ther Adv Respir Dis. 2012;6:173-87.
Hamilton Rg, Marcotte GV, Saini SS. Inmunological methods for quatifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy. J Immunol Methods. 2005;303(1-2):81–91.
Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary apergillosis. J Infect Public Health. 2011;4:235-43.
Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;4:11.